Responses
Electronic pages
Correspondence response
Response to: ‘Does the risk of lymphoma in patients with RA treated with TNF inhibitors differ according to the histological subtype and the type of TNF inhibitor?’ by Nocturne et al
Compose a Response to This Article
Other responses
No responses have been published for this article.